Brian Mueller - 08 Jul 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
08 Jul 2022
Transactions value $
-$656,662
Form type
4
Filing time
12 Jul 2022, 14:25:43 UTC
Previous filing
01 Jul 2022
Next filing
09 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale -$657K -7.34K -19.28% $89.50 30.7K 08 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on March 14, 2022.